Laboratory tests in primary care · by Dr Solange Déplanque and Dr Michaël Rochoy

Fever after return from a tropical country

Infectious diseases · Symptom or situation · updated 2026-11-09

BioMG follows French guidelines. Adapt it to the guidelines and the tests available where you practise.

Frequency: Malaria causes 22% of fevers on return from travel; tropical infections 36%, cosmopolitan infections 36% [1]

Tests the same day (malaria to be ruled out urgently)

Laboratory tests

12 to 24 hours later if the first result is negative or doubtful

Detailed explanation and international comparison (in French): read it in English (machine translation)

Also consider

Do not order

Dengue, chikungunya, Zika: depending on the area and the day of symptoms

Laboratory tests

Detailed explanation and international comparison (in French): read it in English (machine translation)

Do not order

Tests guided by exposure and clinical picture

Depending on the clinical picture

Detailed explanation and international comparison (in French): read it in English (machine translation)

Malaria treated as an outpatient: follow-up

Before primaquine

At day 3 (72 hours)

On D7

At day 14 and day 21 (after intravenous artesunate)

At day 28

Detailed explanation and international comparison (in French): read it in English (machine translation)

Do not order

Sources (13)
  1. Davidson H, Houston A. Fever in the returning traveller. Medicine (Abingdon). 2021;49(11):723-726.
  2. Société de pathologie infectieuse de langue française (SPILF) et sociétés associées. Prise en charge et prévention du paludisme d’importation. Mise à jour 2017 des recommandations pour la pratique clinique de 2007 (texte long).
  3. Caisse nationale de l’assurance maladie. Nomenclature des actes de biologie médicale (NABM), version 105 : actes 1125 et 4364 (paludisme), 4354 (sérologie palustre), 5259 à 5267, 4273, 1254 et 1255 (dengue, chikungunya, Zika).
  4. Lalloo DG, Shingadia D, Bell DJ, Beeching NJ, Whitty CJM, Chiodini PL ; PHE Advisory Committee on Malaria Prevention in UK Travellers. UK malaria treatment guidelines 2016. J Infect. 2016;72(6):635-649.
  5. Shahbodaghi SD, Rathjen NA. Malaria: Prevention, Diagnosis, and Treatment. Am Fam Physician. 2022;106(3):270-278.
  6. Rijksinstituut voor Volksgezondheid en Milieu (RIVM, Pays-Bas), LCI. Richtlijn Malaria. Établie le 19 mai 2026 ; chapitre diagnostic établi le 22 janvier 2025.
  7. Sharp TM, Fischer M, Muñoz-Jordán JL, et al. Dengue and Zika Virus Diagnostic Testing for Patients with a Clinically Compatible Illness and Risk for Infection with Both Viruses. MMWR Recomm Rep. 2019;68(1):1-10.
  8. Rijksinstituut voor Volksgezondheid en Milieu (RIVM, Pays-Bas), LCI. Richtlijn Dengue. Établie le 20 mai 2025 ; chapitre diagnostic révisé le 8 juillet 2026.
  9. UK Health Security Agency. Zika virus: sample testing advice. Mise à jour du 5 août 2026.
  10. Organisation mondiale de la santé. WHO guidelines for clinical management of arboviral diseases: dengue, chikungunya, Zika and yellow fever. Genève : OMS ; 2025 : section 2.6, Laboratory confirmation.
  11. Jauréguiberry S, Paris L, Caumes E. Acute schistosomiasis, a diagnostic and therapeutic challenge. Clin Microbiol Infect. 2010;16(3):225-231.
  12. Advisory Committee on Dangerous Pathogens (ACDP), Royaume-Uni. Viral haemorrhagic fevers risk assessment, algorithme, septembre 2026 ; page mise à jour le 9 septembre 2026.
  13. Robert Koch-Institut (Allemagne). RKI-Ratgeber Malaria. Version révisée d'octobre 2026 (Epidemiologisches Bulletin 44/2026).